Cormorant Asset Management, LP Icosavax, Inc. Transaction History

Cormorant Asset Management, LP

  • $1.3 Billion
  • Q2 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2022

Nov 14, 2022
SELL
$3.09 - $9.21 $23,385 - $69,701
-7,568 Reduced 1.16%
643,825 $2.03 Million
Q2 2022

Aug 15, 2022
BUY
$5.7 - $10.33 $1.28 Million - $2.32 Million
225,000 Added 52.77%
651,393 $3.73 Million
Q3 2021

Nov 15, 2021
BUY
$24.85 - $40.25 $10.6 Million - $17.2 Million
426,393 New
426,393 $12.2 Million

Others Institutions Holding ICVX

# of Institutions
2
Shares Held
1.37M
Call Options Held
0
Put Options Held
0
View Full List

About Icosavax, Inc.

ICVX Quotes by TradingView
  • Ticker ICVX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,885,200
  • Description
  • Icosavax, Inc., a biopharmaceutical company, develops vaccines against infectious diseases. The company, with the help of its virus-like particle (VLP) platform technology, focuses primarily on life-threatening respiratory diseases. Its products in pipeline include IVX-121, a vaccine candidate with RSV target and is under Phase 1/1b clinical tri...
More about ICVX
Track This Portfolio

Track Cormorant Asset Management, LP Portfolio

Follow Cormorant Asset Management, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cormorant Asset Management, LP, based on Form 13F filings with the SEC.

News

Stay updated on Cormorant Asset Management, LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email